Spark Investment Management LLC Arbutus Biopharma Corp Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$0.91 - $2.36 $25,503 - $66,141	-28,026 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.01 - $3.42 $28,306 - $95,848	28,026 New	28,026 $28,000
Q2 2018 Aug 08, 2018	SELL	$5.0 - $7.35 $60,000 - $88,200	-12,000 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$4.4 - $6.05 $48,400 - $66,550	-11,000 Reduced 47.83%	12,000 $60,000
Q4 2017 Feb 12, 2018	BUY	$4.45 - $7.7 $50,730 - $87,780	11,400 Added 98.28%	23,000 $116,000
Q3 2017 Nov 13, 2017	BUY	$3.4 - $7.0 $39,440 - $81,200	11,600	11,600 $71,000

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.